Outlook on the ECG Equipment and Management Systems Global Market to 2027 - Increasing Demand for Ambulatory Monitoring Devices in Developing Markets Presents Opportunities

23 Aug 2022
www.prnewswire.com
Collaborate
DUBLIN, Aug. 23, 2022 /PRNewswire/ -- The "Global ECG Equipment and Management Systems Market (2022-2027) by Type, End-use, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis" report has been added to
ResearchAndMarkets.com's offering.
The Global ECG Equipment and Management Systems Market is estimated to be USD 7.2 Bn in 2022 and is expected to reach USD 10.63 Bn by 2027, growing at a CAGR of 8.1%.
Market dynamics are forces that impact the prices and behaviors of the Global ECG Equipment and Management Systems Market stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service.
Forces of Market Dynamics may be related to macro-economic and micro-economic factors. There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals. As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding the growth and reducing the risks.
Company Profiles
The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are BioTelemetry, CompuMed, Hill-Rom services, Schiller, Nihon Kohden, Koninklijke Philips, GE Healthcare, Spacelabs Healthcare (OSI Systems), McKesson, Dragerwerk, Mindray Bio-Medical Electronics, CardioComm Solutions, Meditech Equipment, Device Technologies, ZOLL Medical, medical ECONET, etc.
Countries Studied
America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)
Competitive Quadrant
The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.
Ansoff Analysis
The report presents a detailed Ansoff matrix analysis for the Global ECG Equipment and Management Systems Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach. The analyst analyses the using the Ansoff Matrix to provide the best approaches a company can take to improve its market position. Based on the SWOT analysis conducted on the industry and industry players, the analyst has devised suitable strategies for market growth.
Why buy this report?
The report offers a comprehensive evaluation of the Global ECG Equipment and Management Systems Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
The report includes an in-depth market analysis using Porter's 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
The report also contains the competitive analysis using Positioning Quadrants, the analyst's Proprietary competitive positioning tool.
Key Topics Covered:
1 Report Description
2 Research Methodology
3 Executive Summary
4 Market Dynamics
4.1 Drivers
4.1.1 Growing Prevalence of Cardiac Arrhythmia
4.1.2 Advancements in ECG Management System
4.2 Restraints
4.2.1 High Cost and Longer Turnaround Time (Tat)
4.2.2 Lack of Supportive Reimbursement Policies
4.3 Opportunities
4.3.1 Increasing Demand for Ambulatory Monitoring Devices in Developing Markets
4.4 Challenges
4.4.1 False-negative and false-positive results
5 Market Analysis
5.2 Porter's Five Forces Analysis
5.3 Impact of COVID-19
5.4 Ansoff Matrix Analysis
6 Global ECG Equipment and Management Systems Market, By Type
6.1 Introduction
6.2 Holter monitoring systems
6.3 Resting ECG System
6.4 Stress ECG Monitors
6.5 Event Monitoring Systems
6.6 ECG Management Systems
7 Global ECG Equipment and Management Systems Market, By End-use
7.1 Introduction
7.3 Ambulatory Facilities
8 Americas' ECG Equipment and Management Systems Market
8.1 Introduction
8.2 Argentina
8.3 Brazil
8.4 Canada
8.5 Chile
8.6 Colombia
8.7 Mexico
8.8 Peru
8.9 United States
8.10 Rest of Americas
9 Europe's ECG Equipment and Management Systems Market
9.1 Introduction
9.2 Austria
9.3 Belgium
9.4 Denmark
9.5 Finland
9.6 France
9.7 Germany
9.8 Italy
9.9 Netherlands
9.10 Norway
9.11 Poland
9.12 Russia
9.13 Spain
9.14 Sweden
9.15 Switzerland
9.16 United Kingdom
9.17 Rest of Europe
10 Middle East and Africa's ECG Equipment and Management Systems Market
10.1 Introduction
10.2 Egypt
10.3 Israel
10.4 Qatar
10.5 Saudi Arabia
10.6 South Africa
10.7 United Arab Emirates
10.8 Rest of MEA
11 APAC's ECG Equipment and Management Systems Market
11.1 Introduction
11.2 Australia
11.3 Bangladesh
11.4 China
11.5 India
11.6 Indonesia
11.7 Japan
11.8 Malaysia
11.9 Philippines
11.10 Singapore
11.11 South Korea
11.12 Sri Lanka
11.13 Thailand
11.14 Taiwan
11.15 Rest of Asia-Pacific
12 Competitive Landscape
12.1 Competitive Quadrant
12.2 Market Share Analysis
12.3 Strategic Initiatives
12.3.1 M&A and Investments
12.3.2 Partnerships and Collaborations
12.3.3 Product Developments and Improvements
13 Company Profiles
13.2 CardioComm Solutions
13.5 Dragerwerk
13.7 Hill-Rom services
13.10 medical ECONET
13.13 Nihon Kohden
13.14 Schiller
13.15 Spacelabs Healthcare (OSI Systems)
14 Appendix
For more information about this report visit https://www.researchandmarkets.com/r/pgcx0j
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
SOURCE Research and Markets
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-
Drugs
-
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.